Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

S. W. Lewis*, L. Davies, P. B. Jones, T. R.E. Barnes, R. M. Murray, R. Kerwin, D. Taylor, K. P. Hayhurst, A. Markwick, H. Lloyd, G. Dunn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Number of pages0
JournalHealth Technology Assessment
Volume10
Issue number17
DOIs
Publication statusE-pub ahead of print - May 2006

Cite this